Systematic review: hydroxyurea for the treatment of adults with sickle cell disease. (atsiveria naujas langas)

Lanzkron S, Strouse JJ, Wilson R, Beach MC, Haywood C, Park H, Witkop C, Bass EB, Segal JB.

Šaltinis‎: Ann Intern Med 2008;148(12):939-55.

Kodas‎: PubMed 18458272

https://www.ncbi.nlm.nih.gov/pubmed/18458272 (atsiveria naujas langas)

Cost-effectiveness of hydroxyurea in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. (atsiveria naujas langas)

Moore RD, Charache S, Terrin ML, Barton FB, Ballas SK.

Šaltinis‎: Am J Hematol 2000;64(1):26-31.

Kodas‎: PubMed 10815784

https://www.ncbi.nlm.nih.gov/pubmed/10815784 (atsiveria naujas langas)

Hydroxyurea for the treatment of sickle cell anemia. (atsiveria naujas langas)

Platt OS.

Šaltinis‎: N Engl J Med 2008;358(13):1362-9.

Kodas‎: PubMed 18367739

DOI‎: 10.1056/NEJMct0708272

https://www.ncbi.nlm.nih.gov/pubmed/18367739 (atsiveria naujas langas)

Clinical effectiveness of decitabine in severe sickle cell disease. (atsiveria naujas langas)

Saunthararajah Y, Molokie R, Saraf S, Sidhwani S, Gowhari M, Vara S, Lavelle D, DeSimone J.

Šaltinis‎: Br J Haematol 2008;141(1):126-9.

Kodas‎: PubMed 18324975

DOI‎: 10.1111/j.1365-2141.2008.07027.x

https://www.ncbi.nlm.nih.gov/pubmed/18324975 (atsiveria naujas langas)

The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS). (atsiveria naujas langas)

Voskaridou E, Christoulas D, Bilalis A, Plata E, Varvagiannis K, Stamatopoulos G, Sinopoulou K, Balassopoulou A, Loukopoulos D, Terpos E.

Šaltinis‎: Blood 2010;115(12):2354-63.

Kodas‎: PubMed 19903897

DOI‎: 10.1182/blood-2009-05-221333

https://www.ncbi.nlm.nih.gov/pubmed/19903897 (atsiveria naujas langas)

Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease. (atsiveria naujas langas)

Hirst C, Owusu-Ofori S.

Šaltinis‎: Cochrane Database Syst Rev 2012;(9):CD003427.

Kodas‎: PubMed 22972063

DOI‎: 10.1002/14651858.CD003427.pub2

https://www.ncbi.nlm.nih.gov/pubmed/22972063 (atsiveria naujas langas)

Voxelotor in adolescents and adults with sickle cell disease (HOPE): long-term follow-up results of an international, randomised, double-blind, placebo-controlled, phase 3 trial. (atsiveria naujas langas)

Howard J, Ataga KI, Brown RC, Achebe M, Nduba V, El-Beshlawy A, Hassab H, Agodoa I, Tonda M, Gray S, Lehrer-Graiwer J, Vichinsky E

Šaltinis‎: Lancet Haematol 2021;8(5):e323-33.

Kodas‎: PubMed 33838113

DOI‎: 10.1016/S2352-3026(21)00059-4

https://www.ncbi.nlm.nih.gov/pubmed/33838113 (atsiveria naujas langas)

Sickle cell disease. (atsiveria naujas langas)

Meremikwu MM, Okomo U.

Šaltinis‎: BMJ Clin Evid 2011;02:2402.

Kodas‎: PubMed 21718552

https://www.ncbi.nlm.nih.gov/pubmed/21718552 (atsiveria naujas langas)

A phase 3 trial of l-glutamine in sickle cell disease. (atsiveria naujas langas)

Niihara Y, Miller ST, Kanter J, Lanzkron S, Smith WR, Hsu LL, Gordeuk VR, Viswanathan K, Sarnaik S, Osunkwo I, Guillaume E, Sadanandan S, Sieger L, Lasky JL, Panosyan EH, Blake OA, New TN, Bellevue R, Tran LT, Razon RL, Stark CW, Neumayr LD, Vichinsky EP

Šaltinis‎: N Engl J Med 2018;379(3):226-35.

Kodas‎: PubMed 30021096

DOI‎: 10.1056/NEJMoa1715971

https://www.ncbi.nlm.nih.gov/pubmed/30021096 (atsiveria naujas langas)

Malaria chemoprophylaxis in sickle cell disease. (atsiveria naujas langas)

Oniyangi O, Omari AA.

Šaltinis‎: Cochrane Database Syst Rev 2006;(4):CD003489.

Kodas‎: PubMed 17054173

DOI‎: 10.1002/14651858.CD003489.pub2

https://www.ncbi.nlm.nih.gov/pubmed/17054173 (atsiveria naujas langas)